The Pharmacy Revolution: How Body Composition Analytics Are Redefining Longevity and Wellness Outcomes

The pharmacy has always been trusted, but never more so than now. As longevity science accelerates and personalized wellness reshapes how we think about health outcomes, pharmacists are facing a critical inflection point: they can remain transaction brokers of medications, or they can become architects of personalized health outcomes. Dis-Chem in South Africa is exploring this opportunity through a groundbreaking pilot program. And what they are building with the Evolt 360 Body Composition Analyzer, together with South African fitness and wellness partners MiFitness, is the template other pharmacy chains will either lead or follow within the next eighteen months.

Understanding the Shift: From Pills to Personalization

The pharmacy industry is experiencing a seismic shift. Customers are no longer satisfied with transactional health interactions. They want to understand their bodies, track meaningful change over time, and receive recommendations that reflect their individual biology, not a generic protocol. The convergence of longevity science, data-driven engagement, and personalized medicine is creating a new category of health retail, and pharmacies that recognize this shift early will own the category.

Longevity science has established what we have long suspected: body composition matters far more than body weight. Research published in the American Journal of Medicine demonstrates that individuals in the highest quartile of muscle mass index show a nineteen percent reduction in all-cause mortality compared to those in the lowest quartile. Similar findings emerge across multiple cohorts: skeletal muscle mass is one of the strongest predictors of longevity, metabolic health, and treatment outcomes across virtually every therapeutic category.

Yet most pharmacies have no visibility into their customers' body composition. They recommend supplements and wellness products based on guesswork, not data. And they miss the opportunity to track real outcomes over time. Dis-Chem recognized this gap and is piloting a solution built around it.

The Dis-Chem Pilot: Integration, Personalization, Outcome-Based Care

When a customer walks into Dis-Chem's pilot facility today, they can complete a full body composition scan using the Evolt 360 Body Composition Analyzer. The scan is fast, non-invasive, and generates reliable and repeatable data on skeletal muscle mass, fat mass, visceral fat, and subcutaneous fat distribution. But the real innovation is not the scan itself. It is what happens next.

Dis-Chem's pilot integration with the Evolt 360 operates through a custom API. The moment a scan completes, the data flows directly into Dis-Chem's platform. The vision is for the system to generate a personalized welcome communication that references the customer's specific body composition, their visceral fat load, their muscle mass baseline, their current metabolic profile. From there, the intent is to present customers with relevant products and services from the Dis-Chem ecosystem, including targeted supplementation, vitamins, nutrition consultation, longevity wellness packages, and ongoing tracking protocols.

The goal is to move well beyond a generic checkout experience and create a data-driven conversation that opens the moment the measurement completes. Where the pilot aims to go is a model where every customer interaction is anchored to their actual body composition, every suggested intervention is designed to drive measurable outcomes, and where elevated visceral fat results can guide customers toward Dis-Chem's in-store clinic services, ensuring those who may need clinical support are connected to it with context and care.

This is the Dis-Chem ecosystem vision at its most powerful. A single scan has the potential to connect a customer to supplements, vitamins, wellness products, and clinical care, all within one trusted environment. The Evolt 360 becomes the intelligent entry point that activates the full breadth of what Dis-Chem has to offer, turning every visit into a personalized health journey rather than a one-off transaction.

Evolt has wrapped the Evolt 360 in Dis-Chem's branding, customized the result sheets with their products and services, and integrated it seamlessly into their pilot customer journey. Dis-Chem has invested significant resources in activation because early indicators suggest customers who receive personalized, outcome-focused interactions have dramatically higher engagement, retention, and health outcomes.

Why the Evolt 360 Matters in This Equation

Not all body composition analyzers are built equal. Competitors in the space offer measurement capability. The Evolt 360 offers something fundamentally different: a purpose-built platform for integration, customization, and outcome-based solutions.

The Evolt 360 delivers clinically reliable and repeatable body composition data that enables genuine outcome tracking over time. But more critically, it is designed from the ground up for partnership integration. Unlike competitors who treat their hardware as a silo, the Evolt 360 architecture supports customization, white-labeling, API integration, and seamless embedding into business workflows. Dis-Chem's pilot did not just install a machine. It is building an entire customer engagement ecosystem around it, powered by the flexibility that only Evolt can provide.

This flexibility, the ability to brand the hardware, customize the output, integrate the data directly into business systems, and build toward personalized outcome-based solutions across supplements, vitamins, and clinical services, is where Evolt differentiates fundamentally from every other player in the body composition market. Competitors are selling hardware. Evolt is enabling outcome-based solutions that drive real customer value and retention.

The Market Opportunity ‍

The numbers support what Dis-Chem's pilot is exploring. The personalized medicine market is projected to grow significantly through 2035, driven directly by demand for data-driven customer engagement and outcome-focused health interventions. Pharmacy loyalty and engagement research shows a clear pattern: customers who receive personalized interactions based on their health data exhibit significantly higher retention rates, product adherence, and lifetime value.

Digital engagement tools that provide tailored information at the right moment, grounded in real biometric data, drive measurable improvements in outcomes and competitive differentiation. The opportunity is especially pronounced in pharmacy, where brands like Dis-Chem already hold deep consumer trust and operate broad ecosystems of products and clinical services. Body composition data is the missing link that connects those assets into a coherent, personalized customer journey.

Dis-Chem is pioneering a model that aims to combine body composition analytics, longevity science, supplement and vitamin guidance, and clinical referral pathways in a fully integrated customer experience, first-to-market for a pharmacy chain at this scale.

A Word from Evolt Leadership

"Body composition data is the foundation of the quantified self. When individuals understand their skeletal muscle mass, their fat distribution, their metabolic baseline, they stop guessing and start optimizing. Dis-Chem's pilot with the Evolt 360 proves that integrating reliable body composition analytics into the pharmacy experience transforms how we deliver outcome-based solutions. This is the future of personalized health."

Ed Zourudis, CEO, Evolt

What This Means for Pharmacy Leadership

The question facing pharmacy chains globally is not whether body composition analytics will become standard in healthcare. Research confirms that skeletal muscle mass is one of the strongest predictors of longevity outcomes, treatment efficacy, and metabolic health. The clinical evidence is settled.

The real question is: will you be the pharmacy chain that pioneers this integration in your market, or will you be catching up to a competitor who did?

Dis-Chem is leading. They have invested in the infrastructure, partnered with a technology provider built for integration and customization, and are building toward an outcome-focused model that treats customers as complete health systems, not transaction points. The vision is for a single scan to activate the full Dis-Chem ecosystem, connecting customers to the supplements, vitamins, wellness products, and clinical services that are most relevant to their individual body composition data.

For pharmacy leaders watching this unfold: the template is being proven in real time. The technology works. The market demand is accelerating. The window to pioneer this in your geography is open. But it will not stay open forever.